Most Active US Penny Stocks to Watch Announced by PSPicks.com. Growlife (OTC:PHOT), Immunotech Laboratories (PINK:IMMB), Swingplane Ventures (OTC:SWVI) Mentioned

Huntington Beach, CA -- (SBWIRE) -- 02/12/2013 -- http://www.PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks in the United States with the potential of fast gains.

Start making 1,000% Gains, join the newsletter at http://www.PSPicks.com

Penny Stocks are extremely risky, but the returns that are possible are virtually unheard of in the big board marketplace. PSPicks feels it's important for all investors to at least consider Penny Stock speculation for their portfolio.

One method of investing in Penny Stocks is to buy or sell Most Active stocks. Stocks that are most active, or showing large amounts of trades may be ready to break out. Here are several Penny Stocks PSPicks.com is watching.

Immunotech Laboratories Inc. (PINK:IMMB) has been breaking out, up over 1000% the last two weeks. Today an interview featuring company founder Harry Zhabilov was released.

Learn about the next Google before the market, subscribe at http://pspicks.com for free.

Growlife Inc. (OTC:PHOT) was up over 15% in todays trading session.

Swingplane Ventures (OTC:SWVI) was up over 20% in Tuesdays trading session.

DISCOVER HIDDEN STOCKS

PSPicks.com is working on its next Undiscovered Company Special Report. These Special Reports typically see fast gains. Reports are issued to members only, Goto http://www.PSPicks.com to subscribe for free. The most recent report is still up over 1500%.

Disclosure: PSPicks is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.